Nurix Therapeutics (NRIX) Return on Invested Capital (2020 - 2025)

Nurix Therapeutics (NRIX) has 5 years of Return on Invested Capital data on file, last reported at 0.01% in Q4 2025.

• Return on Invested Capital for Q4 2025 came in at 0.01%, changed 0.0% year-over-year; the trailing twelve-month figure through Nov 2025 was 0.01% (changed 0.0% YoY), and the FY2025 annual result was 0.01%, changed 0.0% from the prior year.
• Return on Invested Capital improved to 0.01% in Q4 2025 per NRIX's latest filing, from 0.01% in the prior quarter.
• Over five years, Return on Invested Capital peaked at 0.0% in Q1 2021 and troughed at 0.01% in Q1 2024.
• A 4-year average of 0.0% and a median of 0.0% in 2025 frame the typical range for Return on Invested Capital.
• On a YoY basis, Return on Invested Capital climbed as much as 0 bps in 2021 and fell as far as 1 bps in 2021.
• A 4-year view of Return on Invested Capital shows it stood at 0.0% in 2021, then plunged by 73 bps to 0.01% in 2022, then rose by 17 bps to 0.0% in 2024, then tumbled by 33 bps to 0.01% in 2025.
• Business Quant data shows NRIX's Return on Invested Capital at 0.01% in Q4 2025, 0.01% in Q3 2025, and 0.0% in Q2 2025.